News

Managed Healthcare Executive asked some chief executives what their biggest challenge has been, and how they have worked to overcome it. Here’s what they had to say.

The first step to addressing opioid abuse for employers is to identify potential misuse and addiction.

The highest expense for many U.S. households makes this top of mind for employees.

Virtual care comes to the pharmacy chain.

Drug to treat prostate cancer is expected to produce a major windfall for two pharma makers.

FDA approved yet another indication for pembrolizumab (Keytruda) to treat patients with recurrent, locally advanced or metastatic, squamous cell carcinoma of the esophagus (ESCC).

A look at what payers are-or should be-focusing on in terms of their strategy for getting customers.

What a movie can teach you about innovation in your organization.

Where claims are coming from-and how to stop them.

Creating a health ecosystem for our modern-day customer-seniors with evolving healthcare needs and challenges

How MCOs are delivering value to Medicaid populations.

New study shows that billions may be wasted on unnecessary ED visits.

FDA is adding an important new Boxed Warning on the higher-dose version of this drug.

Tips for helping to calm down a bad workplace environment.

How the president’s Advancing American Kidney Health’ Initiative will impact policy.

Following the consumerization trend, Anthem has released an app designed to give members easier physician access.

Due, at least in part, to the substantial increase in the number of sales of New York not-for-profit skilled nursing facilities to for-profit operators since 2015, the Charities Bureau of the New York State Attorney General is subjecting such transactions to increased scrutiny, including objecting to certain of such sales, increasing the time and cost associated with such transactions.

Chronic pain patients on opioid therapy have limited access to primary care providers, which could lead to negative outcomes

How a tool is helping execs define and measure value in oncology.

Clinical trials hold great promise for advancing healthcare-but only if the right patients are found.

How Blue Cross Blue Shield of Massachusetts achieved success with its Alternative Quality Contract payment model.

Why researchers say current brain disorder prevention approaches aren’t adequate.

Study shows that PBMs may lead to higher drug prices.

What today’s seniors expect from healthcare-and how you can deliver it.

New study finds that when providers engage patients with HIV, patients respond more favorably.

FDA approved the first and only ready-to-use insulin for IV infusion in hospitals and acute care settings.

Healthcare providers are ready and planning to assume increased levels of risk through commercial payer and Medicare contracting models and Medicare Advantage.

Customized survivorship plans specific to the cancer the patient endured and the treatment they received are essential.